These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8079812)

  • 1. Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors.
    Tömösközi Z; Bugovics G; Koncz S; Arányi P
    Agents Actions; 1994 Mar; 41(1-2):105-7. PubMed ID: 8079812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of arginine residues in interleukin 1 receptor binding.
    Nanduri VB; Hulmes JD; Pan YC; Kilian PL; Stern AS
    Biochim Biophys Acta; 1991 Dec; 1118(1):25-35. PubMed ID: 1837236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
    Labriola-Tompkins E; Chandran C; Kaffka KL; Biondi D; Graves BJ; Hatada M; Madison VS; Karas J; Kilian PL; Ju G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11182-6. PubMed ID: 1837145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I IL-1 receptor: ligand specific confirmation differences and the role of glycosylation in ligand binding.
    Einstein R; Jackson JR; D'Alessio K; Lillquist JS; Sathe G; Porter T; Young PR
    Cytokine; 1996 Mar; 8(3):206-13. PubMed ID: 8833035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis--molecular biology and rational drug design.
    Ju G; Labriola-Tompkins E; Varnell T; Madison V; Graves B
    Agents Actions Suppl; 1995; 47():155-9. PubMed ID: 7785490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent binding of interleukin-1 alpha and interleukin-1 beta to type I and type II interleukin-1 receptors.
    Slack J; McMahan CJ; Waugh S; Schooley K; Spriggs MK; Sims JE; Dower SK
    J Biol Chem; 1993 Feb; 268(4):2513-24. PubMed ID: 8428929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of human IL-1 alpha: identification of residues required for binding to the human type I IL-1 receptor.
    Labriola-Tompkins E; Chandran C; Varnell TA; Madison VS; Ju G
    Protein Eng; 1993 Jul; 6(5):535-9. PubMed ID: 7692435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes.
    Pousset F; Cremona S; Dantzer R; Kelley KW; Parnet P
    J Neurochem; 2001 Nov; 79(4):726-36. PubMed ID: 11723165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid difference between human and monkey interleukin (IL)-1beta dictates effective binding to soluble type II IL-1 receptor.
    Smith DE; Ketchem RR; Moore H; Anderson Z; Renshaw BR; Friend DJ; Sims JE
    J Biol Chem; 2002 Dec; 277(49):47619-25. PubMed ID: 12356774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.
    Symons JA; Young PR; Duff GW
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1714-8. PubMed ID: 7878046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.
    Li S; Neff CP; Barber K; Hong J; Luo Y; Azam T; Palmer BE; Fujita M; Garlanda C; Mantovani A; Kim S; Dinarello CA
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2497-502. PubMed ID: 25654981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic C-terminal peptide of IL-1 functions as a binding domain as well as an antagonist for the IL-1 receptor.
    Palaszynski EW
    Biochem Biophys Res Commun; 1987 Aug; 147(1):204-11. PubMed ID: 2958006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities.
    Strassmann G; D'Alessandro F; Fong M; Nordan RP; Nickel P; Chizzonite R
    Int J Immunopharmacol; 1994 Nov; 16(11):931-9. PubMed ID: 7868298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.
    Vigers GP; Anderson LJ; Caffes P; Brandhuber BJ
    Nature; 1997 Mar; 386(6621):190-4. PubMed ID: 9062193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of type I IL-1 beta receptor fragment 151-162 to interleukin-1 beta.
    Fasina G; Verdoliva A; Cassani G; Melli M
    Growth Factors; 1994; 10(2):99-106. PubMed ID: 8068354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding and biological activity of IL-1 alpha, IL-1 beta, IL-1 beta analogues and an IL-1 antagonist in A375 human melanoma cells.
    Baumann JB; Christen E; Gamboni G; Joss U; van Oostrum J; Girard J; Eberle AN
    J Recept Res; 1993; 13(1-4):245-62. PubMed ID: 8450493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
    Ambrosetti DC; Palla E; Mirtella A; Galeotti C; Solito E; Navarra P; Parente L; Melli M
    Eur J Biochem; 1996 Jun; 238(2):308-16. PubMed ID: 8681939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands.
    Malinowsky D; Chai Z; Bristulf J; Simoncsits A; Bartfai T
    Neurosci Lett; 1995 Dec; 201(1):33-6. PubMed ID: 8830306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.